SecSonar.com

AptarGroup, Inc. (ATR)

AptarGroup, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

AptarGroup, Inc. (ATR) is a Medical - Instruments & Supplies company based in US with a market capitalization of $7.4B. Revenue grew 5.4% year-over-year and the company generated $299.6M in free cash flow. This page tracks ATR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 13K employees · IPO Apr 23, 1993

Valuation

Valuation & price

$114.67 · as of May 17, 2026 · -29.1% vs 52w high

19.5

P/E ratio

Latest-FY diluted EPS

2.78

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$162$137$112Jul 25Dec 25Jul 26Jul 7, 25$160.96Jul 9, 25$159.73Jul 11, 25$157.90Jul 15, 25$154.16Jul 17, 25$156.03Jul 21, 25$155.45Jul 23, 25$161.66Jul 25, 25$160.99Jul 29, 25$158.82Jul 31, 25$157.14Aug 4, 25$139.13Aug 6, 25$138.54Aug 11, 25$139.87Aug 13, 25$141.43Aug 15, 25$138.72Aug 19, 25$139.59Aug 21, 25$140.64Aug 25, 25$139.56Aug 27, 25$139.44Aug 29, 25$139.27Sep 3, 25$135.22Sep 5, 25$138.62Sep 9, 25$137.05Sep 11, 25$137.10Sep 16, 25$135.21Sep 18, 25$134.50Sep 22, 25$132.72Sep 24, 25$131.50Sep 26, 25$132.29Sep 30, 25$133.66Oct 2, 25$133.18Oct 6, 25$131.88Oct 8, 25$131.61Oct 10, 25$130.93Oct 14, 25$129.80Oct 16, 25$129.16Oct 21, 25$130.57Oct 23, 25$130.77Oct 27, 25$128.78Oct 29, 25$124.31Oct 31, 25$116.01Nov 4, 25$114.18Nov 6, 25$116.15Nov 10, 25$116.38Nov 12, 25$118.16Nov 14, 25$118.61Nov 18, 25$119.31Nov 20, 25$118.58Nov 25, 25$123.44Nov 28, 25$124.75Dec 2, 25$121.60Dec 4, 25$122.02Dec 8, 25$120.07Dec 10, 25$117.17Dec 12, 25$121.47Dec 16, 25$122.83Dec 18, 25$122.62Dec 22, 25$122.74Dec 24, 25$122.75Dec 29, 25$123.21Jan 2, 26$122.54Jan 6, 26$120.56Jan 8, 26$122.44Jan 12, 26$125.13Jan 14, 26$126.85Jan 16, 26$124.71Jan 21, 26$125.01Jan 23, 26$126.00Jan 27, 26$124.74Jan 29, 26$123.85Feb 2, 26$124.83Feb 4, 26$129.23Feb 9, 26$138.47Feb 11, 26$140.01Feb 13, 26$142.58Feb 18, 26$141.72Feb 20, 26$145.05Feb 24, 26$144.14Feb 26, 26$141.79Mar 2, 26$142.67Mar 4, 26$137.04Mar 6, 26$132.08Mar 10, 26$132.13Mar 12, 26$128.86Mar 17, 26$129.50Mar 19, 26$123.97Mar 23, 26$124.14Mar 25, 26$125.82Mar 27, 26$121.99Mar 31, 26$126.02Apr 2, 26$126.01Apr 7, 26$125.61Apr 9, 26$131.40Apr 13, 26$132.11Apr 15, 26$129.65Apr 17, 26$130.63Apr 22, 26$124.55Apr 24, 26$124.08Apr 28, 26$125.77Apr 30, 26$123.68May 4, 26$120.60May 6, 26$122.63May 8, 26$120.99May 12, 26$118.05May 14, 26$117.99May 18, 26$115.81May 20, 26$115.26May 22, 26$116.23May 28, 26$115.99Jun 1, 26$112.38Jun 3, 26$112.53Jun 5, 26$113.36Jun 9, 26$115.90Jun 11, 26$116.58Jun 15, 26$118.08Jun 17, 26$119.99Jun 22, 26$120.00Jun 24, 26$124.28Jun 26, 26$125.98Jul 2, 26$126.98
$111.9452-week range$161.82
Loading valuation history…

Fundamentals

Key fundamentals

$7.4B

Market cap

5.4%

Revenue growth (YoY)

29.6%

Gross margin

$299.6M

Free cash flow (USD)

$1.1B

Net debt

-0.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$2.3BFY 2017$2.5BFY 2018$2.8BFY 2019$2.9BFY 2020$2.9BFY 2021$3.2BFY 2022$3.3BFY 2023$3.5BFY 2024$3.6BFY 2025$3.8B
$2.3B$3.8B

Free cash flow by year

2016 → 2025

FY 2016$193.8MFY 2017$168.1MFY 2018$101.8MFY 2019$267.4MFY 2020$318.1MFY 2021$55.5MFY 2022$163.0MFY 2023$256.8MFY 2024$349.2MFY 2025$299.6M
$193.8M$299.6M

Gross margin by year

2021 → 2025

FY 202135.8%FY 202235.0%FY 202336.2%FY 202437.8%FY 202529.6%
35.8%29.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

4

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $578KPrieur Marc · Segment President · $577.9KJun 10, 2026Filing
  • Insider sellInsider Sell $400KVinczeller Shiela · Chief Human Resources Officer · $400.3KJun 5, 2026Filing
  • Insider sellInsider Sell $488KGong Xiangwei · President, Asia · $487.8KMay 27, 2026Filing
  • 8-K eventCFO AppointmentMay 13, 2026Filing
  • Insider sellInsider Sell $156KHudson Irene Elizabeth · EVP and Chief Legal Officer · $156KMay 8, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 1, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing

Questions

Frequently asked questions

What is AptarGroup, Inc.'s market cap?

AptarGroup, Inc. (ATR) has a market capitalization of $7.4B.

What is ATR's P/E ratio?

ATR trades at a price-to-earnings ratio of 19.5, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ATR's price-to-book (P/B) ratio?

ATR trades at 2.78 times book value per share.

Are insiders buying ATR stock?

SEC Form 4 filings show no open-market insider buys at AptarGroup, Inc. in the last 90 days (4 sells).

Same arena

Related companies in Medical - Instruments & Supplies

RGEN

Repligen Corporation

$7.1B

AVTR

Avantor, Inc.

$6.4B

TFX

Teleflex Incorporated

$5.7B

STVN

Stevanato Group S.p.A.

$5.2B

BAX

Baxter International Inc.

$9.8B

MMSI

Merit Medical Systems, Inc.

$3.8B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.